Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women

Breast Cancer Research and Treatment

Volumn 136, Issue 1, 2012, Pages 277-287

  Bertrand, Kimberly A ^a,b   Eliassen, A Heather ^b   Hankinson, Susan E ^a,b,c   Gierach, Gretchen L ^d   Xu, Xia ^e   Rosner, Bernard ^a,b   Ziegler, Regina G ^d   Tamimi, Rulla M ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e SAIC FREDERICK INC   (United States)

Author keywords

Breast cancer; Epidemiology; Estradiol; Estrogen metabolites; Mammographic density

Indexed keywords

16 OXOESTRADIOL; 16ALPHA HYDROXYESTRONE; 17 EPIESTRIOL; 2 HYDROXYESTRADIOL; 2 HYDROXYESTRONE; 2 HYDROXYESTRONE 3 METHYL ETHER; 2 METHOXYESTRADIOL; 2 METHOXYESTRONE; EPIESTRIOL; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; COHORT ANALYSIS; COMPUTER ASSISTED RADIOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ESTROGEN URINE LEVEL; FEMALE; HUMAN; HYDROXYLATION; LUTEAL PHASE; MAJOR CLINICAL STUDY; MAMMOGRAPHIC DENSITY; METABOLISM; PREMENOPAUSE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS;

ADULT; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; ESTROGENS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MIDDLE AGED; PLACENTAL HORMONES; PREMENOPAUSE; RISK FACTORS; TANDEM MASS SPECTROMETRY;

EID: 84867877532     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2240-0     Document Type: Article

References (35)

1. Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8):606-616
2. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96(24):1856-1865. doi: 10.1093/jnci/djh336
3. Walker K, Bratton DJ, Frost C (2011) Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis. Br J Cancer 105(9):1451-1457. doi: 10.1038/bjc.2011.358
4. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quiros JR, Roddam A, Thiebaut A, Tjonneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97(10):755-765. doi: 10.1093/jnci/dji132
5. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE (2006) Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98(19):1406-1415. doi: 10.1093/jnci/djj376
6. McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6):1159-1169. doi: 10.1158/1055-9965.EPI-06-0034
7. Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S (2010) Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst 102(16):1224-1237. doi: 10.1093/jnci/djq239
8. Martin LJ, Boyd NF (2008) Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 10 (1):201. doi: 10.1186/bcr1831
9. Bradlow HL, Hershcopf RJ, Martucci CP, Fishman J (1985) Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci USA 82(18):6295-6299
10. Eliassen AH, Spiegelman D, Xu X, Keefer LK, Veenstra TD, Barbieri RL, Willett WC, Hankinson SE, Ziegler RG (2012) Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Cancer Res 72(3):696-706. doi: 10.1158/0008-5472.CAN-11-2507
11. Riza E, dos Santos Silva I, De Stavola B, Bradlow HL, Sepkovic DW, Linos D, Linos A (2001) Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women. Cancer Epidemiol Biomarkers Prev 10(6):627-634
12. Maskarinec G, Williams AE, Rinaldi S, Kaaks R (2005) Mammographic densities and urinary hormones in healthy women with different ethnic backgrounds. In: Li JJ, Li S, Daling JR (eds) Hormonal carcinogensis IV: Proceedings of the fourth international symposium. Springer, New York, pp 277-286
13. Fuhrman BJ, Brinton LA, Pfeiffer RM, Xu X, Veenstra TD, Teter BE, Byrne C, Dallal CM, Barba M, Muti P, Gierach GL (2012) Estrogen metabolism and mammographic density in postmenopausal women: a cross-sectional study. Cancer Epidemiol Biomarkers Prev. doi: 10.1158/1055-9965.EPI-12-0247
14. Maskarinec G, Heak S, Morimoto Y, Custer L, Franke AA (2012) The relation of urinary estrogen metabolites with mammographic densities in premenopausal women. Cancer Epidemiol. doi: 10.1016/j.canep. 2012.03.014
15. Yong M, Schwartz SM, Atkinson C, Makar KW, Thomas SS, Newton KM, Aiello Bowles EJ, Holt VL, Leisenring WM, Lampe JW (2010) Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States. Cancer Epidemiol Biomarkers Prev 19(2):537-546. doi: 10.1158/1055-9965.EPI-09-0898
16. Byng JW, Boyd NF, Little L, Lockwood G, Fishell E, Jong RA, Yaffe MJ (1996) Symmetry of projection in the quantitative analysis of mammographic images. Eur J Cancer Prev 5(5):319-327
17. Pettersson A, Hankinson SE, Willett WC, Lagiou P, Trichopoulos D, Tamimi RM (2011) Nondense mammographic area and risk of breast cancer. Breast Cancer Res 13 (5):R100. doi: 10.1186/bcr3041
18. Rosner B, Cook N, Portman R, Daniels S, Falkner B (2008) Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol 167(6):653-666. doi: 10.1093/aje/kwm348
19. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60(14):3744-3748
20. Tamimi RM, Hankinson SE, Colditz GA, Byrne C (2005) Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2641-2647. doi: 10.1158/1055-9965.EPI-05- 0558
21. Stone J, Ding J, Warren RM, Duffy SW, Hopper JL (2010) Using mammographic density to predict breast cancer risk: dense area or percentage dense area. Breast Cancer Res 12(6):R97. doi: 10.1186/bcr2778
22. Lokate M, Peeters PH, Peelen LM, Haars G, Veldhuis WB, van Gils CH (2011) Mammographic density and reast cancer risk: the role of the fat surrounding the fibroglandular tissue. Breast Cancer Res 13(5):R103. doi: 10.1186/bcr3044
23. Falk RT, Xu X, Keefer L, Veenstra TD, Ziegler RG (2008) A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol Biomarkers Prev 17(12):3411-3418. doi: 10.1158/1055-9965.EPI-08-0355
24. Xu X, Veenstra TD, Fox SD, Roman JM, Issaq HJ, Falk R, Saavedra JE, Keefer LK, Ziegler RG (2005) Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem 77(20):6646-6654. doi: 10.1021/ac050697c
25. Ziegler RG, Faupel-Badger JM, Sue LY, Fuhrman BJ, Falk RT, Boyd-Morin J, Henderson MK, Hoover RN, Veenstra TD, Keefer LK, Xu X (2010) A new approach to measuring estrogen exposure and metabolism in epidemiologic studies. J Steroid Biochem Mol Biol 121(3-5):538-545. doi: 10.1016/j.jsbmb.2010.03.068
26. Matthews CE, Fortner RT, Xu X, Hankinson SE, Eliassen AH, Ziegler RG (2012) Association between physical activity and urinary estrogens and estrogen metabolites in premenopausal women. J Clin Endocrinol Metab. doi: 10.1210/jc.2012-1732
27. Xie J, Eliassen AH, Xu X, Mathews CE, Hankinson SE, Ziegler RG, Tworoger SS (in press) Body size in relation to urinary estrogens and estrogen metabolites (EM) among premenopausal women during the luteal phase. Hormones Cancer
28. Fortner RT, Hankinson SE, Schairer C, Xu X, Ziegler RG, Eliassen AH (2012) Association between reproductive factors and urinary estrogens and estrogen metabolites in premenopausal women. Cancer Epidemiol Biomarkers Prev. doi: 10.1158/1055-9965.EPI-12-0171
29. Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 25:165-172
30. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA (2000) Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 11(7):653-662
31. Boyd NF, Lockwood GA, Byng JW, Little LE, Yaffe MJ, Tritchler DL (1998) The relationship of anthropometric measures to radiological features of the breast in premenopausal women. Br J Cancer 78(9):1233-1238
32. Samimi G, Colditz GA, Baer HJ, Tamimi RM (2008) Measures of energy balance and mammographic density in the Nurses' Health Study. Breast Cancer Res Treat 109(1):113-122. doi: 10.1007/s10549-007-9631-7
33. Eliassen AH, Ziegler RG, Rosner B, Veenstra TD, Roman JM, Xu X, Hankinson SE (2009) Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev 18(11):2860-2868. doi: 10.1158/1055-9965.EPI-09-0591
34. Taioli E, Im A, Xu X, Veenstra TD, Ahrendt G, Garte S (2010) Comparison of estrogens and estrogen metabolites in human breast tissue and urine. Reprod Biol Endocrinol 8:93. doi: 10.1186/1477-7827-8-93
35. Fuhrman BJ, Schairer C, Gail MH, Boyd-Morin J, Xu X, Sue LY, Buys SS, Isaacs C, Keefer LK, Veenstra TD, Berg CD, Hoover RN, Ziegler RG (2012) Estrogen metabolism and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 104(4):326-339. doi: 10.1093/jnci/djr531